Evidence map›Paper›PMID 39898759›Full record

ReviewBlood cancer discovery2025

Addressing Health Disparities in Hematologic Malignancies: from Genes to Outreach.

Christopher R Flowers, Rachel W Anantha, Veronica Leautaud, Pinkal Desai, Chancellor E Donald, Michelle A T Hildebrandt, Jean L Koff, Rulla M Tamimi, Wendy Cozen, Chijioke Nze and 1 more

Abstract readReview
In one paragraph

Review in Blood cancer discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Christopher R FlowersDepartment of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0002-9524-3990
Rachel W AnanthaDepartment of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0009-0000-6831-9227
Veronica LeautaudDepartment of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0009-0009-5103-0684
Pinkal DesaiDivision of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York.ORCID 0000-0002-9816-7284
Chancellor E DonaldSection of Hematology and Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana.ORCID 0009-0008-6982-7619
Michelle A T HildebrandtDepartment of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0001-6769-6872
Jean L KoffDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.ORCID 0000-0003-4414-0489
Rulla M TamimiDivision of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York.ORCID 0000-0003-2306-8668
Wendy CozenDivision of Hematology and Oncology, Department of Medicine, School of Medicine, University of California Irvine, Irvine, California.ORCID 0000-0003-3415-8247
Chijioke NzeDepartment of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0001-9715-2577
Ari M MelnickDivision of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York.ORCID 0000-0002-8074-2287

Funding

The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (Supplement)U01CA195568 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R, FLOWERS, CHRISTOPHER R · 2015 to 2025
$22.1M
Project 4 Green-DavisP01CA272295 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Leandro C Cerchietti, CHRISTOPHER R FLOWERS · 2024 to 2026
$9.3M
NCI NIH HHS P01 CA272295NCI NIH HHS U01 CA195568NCI NIH National Cancer Institute R01-CA242069-S1
6 · The paper itself

Abstract

significanceThis review underscores our shared responsibility to champion multidimensional strategies rooted in basic and translational science, community involvement, and societal responsiveness for a meaningful impact. Unifying themes include the need to enhance collaborative infrastructure to engage laboratory researchers, epidemiologists, data scientists, clinicians, patients, community leaders, and policymakers; patient-level support services; outreach, education, and navigation for patients at the community level; recruitment and retention of underrepresented groups in the healthcare and research workforce; and funding for these efforts.

Indexed as

Healthcare DisparitiesHealth Status DisparitiesHematologic NeoplasmsHumans

Identifiers

PMID39898759
PMCPMC11876954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.